Laetrile Therapy, Cancer
In this video, Gilberto Alvarez spends about 22 minutes speaking on "Laetrile Therapy, Cancer" at the 34th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Dr. Gilberto Alvarez
Dr. Gilberto Alvarez is a medical doctor who graduated from the National Autonomous University in Mexico City and practices medicine in both Mexico and the United States. He has over 37 years of experience and a longtime practice in integrative and natural medicine for cancer patients. Between the years 1977 and 1981, he worked with Dr. Ernesto Contreras, a well-recognized doctor, founder of Oasis of Hope clinic in Tijuana, and the first doctor to have brought the German methods of therapy to Mexico.
Between 1982 and 1992 he was the medical director at Dr. Harold W. Manner’s clinic, pioneering in nutritional therapy based on laetrile and vitamins. Later on, Dr. Alvarez became the medical director at Stella Maris from 1993 until today. He participated on Proteolytic Enzyme Therapy in Munich, Germany with Dr. Karl Ransberger. He then became a member of the International Clinical Hyperthermia Society (ICHS) in Florence, Italy in 2005. His experience in cancer and other disorders is extensive, and he implements his expertise in different programs given at his clinic.
On a personal level, Dr. Alvarez is a warm person who sees the patient as a whole and shows genuine caring and empathy. He answers patients’ calls personally before and after treatment.
Transcription
If I could make out my. Good evening. Good evening, ladies and gentlemen. It is my pleasure. Be able to share with you the experience that we have accumulated for the last 25 years of Stella Meyer's clinic.
Actually, I'm going to open my presentation with one important aspect of what metabolic therapy is and what the typical oncology oncologist has to face. Every time we deal with a cancer patient and this is in regards what we call tumors, tumor cell resistance. And this is actually the big issue, why many, many cancer cases do not succeed. Do not respond. And this is pretty much shameful. But for that particular situation of the tumor cell resistant, which is pretty much influence, but three main factors. And these are the a constant DNA mutation, the a protein called the surrounds these cancer cells. And third, this is when the patients either undergo too much chemo and already gene therapy. So Axtell Amar's clinic, what we're doing, we're working in three different areas. We're working at Drucilla homeostasis through a natural cancer attacking system and through immuno immunomodulators. So we have to ensure that our patients really get in being in the best position to respond to our natural therapies. So we have to act out at all different levels to do the yes. The system, the circulatory system, the lymphatic system for one purpose, to enhance your cell for a better functioning.
Now we are to eliminate all these talks that we are exposed to through the standard chemo drugs, through air pollution, too many things that really impair yourself for a good functioning. So this is one priority of the. We have to do everything with me, the one pitching into our clinic. Meantime, we have to ensure that our patients improve their intestinal absorption. So we're using different methods where where we we can ensure that our patients really improve the intestinal fortune. We're using certain stimulants which are administered true through antima and estriol the caffeine where we can stimulate the gallbladder and empty in the bile contin into the small intestines. By doing so, we're automatically improving your intestinal absorption. Where the patient will be able to retain better your insides, the bottom it's. And the nutrients.
So it's also important that we provide the ideal oxygen and energy delivery into the cell. So the reasoning is why all these Auxier radicals will impair your cell as well. It will be impairing your own immune system from an adequate functioning. So where we're using all these antioxidants and what the wonder we focus the most will be through the intravenous. Also, where will the patients stay